Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Retatrutide is a triple-receptor agonist peptide studied in metabolic research for its simultaneous activation of GLP-1, GIP, and glucagon receptors , making it the most advanced multi-pathway metabolic research compound currently available and representing the next generation beyond dual-receptor peptides like Tirzepatide and Semaglutide
There is a faster track called Priority Review (6 months) for drugs that represent a major improvement over what is already available
Adverse events caused treatment discontinuation in 4.3%, 7.1%, 6.2%, and 2.6% of participants receiving 5-mg, 10-mg, 15-mg tirzepatide doses and placebo, respectively [49]
Our vials and packaging are held to high industry standards, delivering consistent quality from one batch to the next
US$ 22.86
US$ 27.96
US$ 26.00
US$ 24.03
US$ 21.46
